{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:36:49Z","timestamp":1783129009470,"version":"3.54.6"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:00:00Z","timestamp":1607040000000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Dermatol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Scleromyxedema is a rare, para-neoplastic, chronic, progressive condition of the Lichen myxedematosus (LM) family. The clinical picture consists of generalized confluent papular eruptions with possible systemic manifestations, which may be fatal as it still constitutes a therapeutic dilemma. Histologically, it is characterized by dermal mucin deposition, fibroblast proliferation with fibrosis, with monoclonal gammopathy in the absence of thyroid disease. Some atypical forms of the disease were reported in the literature, but none were reported in acute leukemia.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>Herein, we report a case of a 21\u00a0years old female patient, known case of acute lymphoblastic leukemia (ALL), who developed numerous hyper-pigmented erythematous papules and plaques, mainly over her thighs, lower abdomen, and sub-mammary flexures. Histopathology of skin lesions confirmed the diagnosis of atypical scleromyxedema. Her symptoms significantly improved with the use of high dose intravenous immunoglobulin (IVIG).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Despite that scleromyxedema is associated with many hematologic disorders, it is very rarely associated with acute lymphoblastic leukemia, and a high index of suspicion is needed for diagnosis. IVIG remains a reasonable management of such a disabling disease.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12895-020-00118-7","type":"journal-article","created":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T13:04:10Z","timestamp":1607087050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Scleromyxedema in a 21\u00a0year old female patient with acute lymphoblastic leukemia: a case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Hadi","family":"Rabee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leeda","family":"Tayem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Gharbeyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Abugaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,4]]},"reference":[{"issue":"1","key":"118_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1046\/j.1525-1470.2002.00007.x","volume":"19","author":"ML Nebrida","year":"2002","unstructured":"Nebrida ML, Tay YK. Cutaneous focal mucinosis: a case report. Pediatr Dermatol. 2002;19(1):33\u20135.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"118_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/00000372-200106000-00022","volume":"23","author":"F Rongioletti","year":"2001","unstructured":"Rongioletti F, Rebora A. Cutaneous mucinoses: microscopic criteria for diagnosis. Am J Dermatopathol. 2001;23(3):257\u201367.","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"118_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1067\/mjd.2001.111630","volume":"44","author":"F Rongioletti","year":"2001","unstructured":"Rongioletti F, Rebora A. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol. 2001;44(2):273\u201381.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"118_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/00005792-198801000-00004","volume":"67","author":"SE Gabriel","year":"1988","unstructured":"Gabriel SE, Perry HO, Oleson GB, Bowles CA. Scleromyxedema: a scleroderma-like disorder with systemic manifestations. Med (Baltim). 1988;67(1):58\u201365.","journal-title":"Med (Baltim)"},{"issue":"5","key":"118_CR5","first-page":"45","volume":"7","author":"L Caudill","year":"2014","unstructured":"Caudill L, Howell E. Scleromyxedema: a case clinically and histologically responsive to intravenous immunoglobulin. J Clin Aesthet Dermatol. 2014;7(5):45\u20137.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"5","key":"118_CR6","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1590\/S0365-05962004000500006","volume":"79","author":"GA Martins","year":"2004","unstructured":"Martins GA, Abdala WG, Andrade DV. Escleromixedema associado a miocardiopatia. An Bras Dermatol. 2004;79(5):561\u20136.","journal-title":"An Bras Dermatol"},{"issue":"2","key":"118_CR7","first-page":"215","volume":"60","author":"JC Salas-Alanis","year":"2015","unstructured":"Salas-Alanis JC, Martinez-Jaramillo B, Gomez-Flores M, Ocampo-Candiani J. Scleromyxedema, a therapeutic dilemma. Indian J Dermatol. 2015;60(2):215.","journal-title":"Indian J Dermatol"},{"issue":"2","key":"118_CR8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000353178","volume":"5","author":"M Allam","year":"2013","unstructured":"Allam M, Ghozzi M. Scleromyxedema: a case report and review of the literature. Case Rep Dermatol. 2013;5(2):168\u201375.","journal-title":"Case Rep Dermatol"},{"issue":"5","key":"118_CR9","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jdcr.2017.04.005","volume":"3","author":"SJ Oh","year":"2017","unstructured":"Oh SJ, Oh SH, Jun JY, Park JH, Lee JH, Lee DY, et al. Paraneoplastic atypical scleromyxedema with advanced gastric cancer. JAAD Case Rep. 2017;3(5):376\u20138.","journal-title":"JAAD Case Rep"},{"issue":"2","key":"118_CR10","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.sder.2006.04.001","volume":"25","author":"F Rongioletti","year":"2006","unstructured":"Rongioletti F. Lichen myxedematosus (papular mucinosis): new concepts and perspectives for an old disease. Semin Cutan Med Surg. 2006;25(2):100\u20134.","journal-title":"Semin Cutan Med Surg"},{"issue":"2","key":"118_CR11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1182\/blood-2004-12-4870","volume":"107","author":"ML Donato","year":"2006","unstructured":"Donato ML, Feasel AM, Weber DM, Prieto VG, Giralt SA, Champlin RE, et al. Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation. Blood. 2006;107(2):463\u20136.","journal-title":"Blood"},{"issue":"5 suppl 1","key":"118_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1590\/abd1806-4841.20164527","volume":"91","author":"AC Sala","year":"2016","unstructured":"Sala AC, Cunha PR, Pinto CA, Alves CA, Paiva IB, Araujo AP. Scleromyxedema: clinical diagnosis and autopsy findings. An Bras Dermatol. 2016;91(5 suppl 1):48\u201350.","journal-title":"An Bras Dermatol"},{"issue":"11","key":"118_CR13","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/art.1780311115","volume":"31","author":"DJ Helfrich","year":"1988","unstructured":"Helfrich DJ, Walker ER, Martinez AJ, Medsger TA. Jr. Scleromyxedema myopathy: case report and review of the literature. Arthritis Rheum. 1988;31(11):1437\u201341.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"118_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.5152\/eurjrheum.2015.0116","volume":"2","author":"Y Savran","year":"2015","unstructured":"Savran Y, Akarsu S. Dermato-neuro syndrome in a case of scleromyxedema. Eur J Rheumatol. 2015;2(4):160\u20132.","journal-title":"Eur J Rheumatol"},{"issue":"10","key":"118_CR15","doi-asserted-by":"publisher","first-page":"e539-43","DOI":"10.1111\/ijd.13315","volume":"55","author":"R Chockalingam","year":"2016","unstructured":"Chockalingam R, Duvic M. Scleromyxedema: long-term follow-up after high-dose melphalan with autologous stem cell transplantation. Int J Dermatol. 2016;55(10):e539-43.","journal-title":"Int J Dermatol"},{"issue":"3","key":"118_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000452319","volume":"8","author":"S Saniee","year":"2016","unstructured":"Saniee S, Davarnia G. Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone. Case Rep Dermatol. 2016;8(3):327\u201332.","journal-title":"Case Rep Dermatol"},{"issue":"Suppl 1","key":"118_CR17","doi-asserted-by":"publisher","first-page":"A97","DOI":"10.1186\/1546-0096-10-S1-A97","volume":"10","author":"DW Moser","year":"2012","unstructured":"Moser DW, Griffin TA. Treatment of scleromyxedema with IVIg. Pediatr Rheumatol Online J. 2012;10(Suppl 1):A97.","journal-title":"Pediatr Rheumatol Online J"},{"key":"118_CR18","doi-asserted-by":"crossref","unstructured":"Lister RK, Jolles S, Whittaker S, Black C, Forgacs I, Cramp M, et al. Scleromyxedema: Response to high-dose intravenous immunoglobulin (hdIVIg). J Am Acad Dermatol. 2000;43(2):p..art 2):403\u20138.","DOI":"10.1067\/mjd.2000.104001"}],"container-title":["BMC Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12895-020-00118-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12895-020-00118-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12895-020-00118-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T13:14:52Z","timestamp":1607087692000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcdermatol.biomedcentral.com\/articles\/10.1186\/s12895-020-00118-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["118"],"URL":"https:\/\/doi.org\/10.1186\/s12895-020-00118-7","relation":{},"ISSN":["1471-5945"],"issn-type":[{"value":"1471-5945","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"30 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This is a case report with no identifiable content; despite this, written consent form was taken from the patient herself for participation and publication.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"\u00a0Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and\/or clinical images was obtained from the patient herself. A copy of the consent form is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}